ICL Israel Chemicals Ltd

Basic Materials · Agricultural Inputs

5.00$ +1.4% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Balance Sheet

ICL Israel Chemicals Ltd (ICL) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 12,413 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ICL
Line item	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Total Assets	2,940	2,993	2,991	3,062	3,324	3,616	4,633	5,738	5,908	6,388	7,283	7,747	7,973	8,348	9,077	8,552	8,714	8,749	9,173	9,664	11,080	11,750	11,627	11,321	12,413
Current Assets	1,059	1,058	1,043	1,202	1,387	1,636	2,252	2,963	2,771	3,130	3,443	3,310	3,042	3,140	2,985	2,571	2,725	2,761	2,684	2,841	3,909	4,548	4,034	3,586	4,164
Cash	16	15	27	37	57	50	58	215	258	401	330	289	188	131	161	87	83	121	95	214	473	417	420	327	291
Cash & Short-Term Investments	41	31	85	188	116	171	132	340	426	894	474	461	285	247	248	116	173	213	191	314	564	508	592	442	496
Receivables	496	478	369	456	562	578	1,050	1,312	1,066	1,058	1,497	1,223	1,057	1,289	1,286	1,148	1,114	1,233	1,130	1,227	1,676	1,826	1,617	1,461	1,624
Inventory	492	506	540	510	653	799	975	1,278	1,233	1,114	1,411	1,480	1,408	1,335	1,364	1,267	1,226	1,290	1,312	1,250	1,570	2,134	1,703	1,626	1,934
Property, Plant & Equipment	–	–	–	–	–	–	–	–	–	–	–	3,097	3,686	3,927	4,212	4,309	4,521	4,663	5,331	5,550	5,754	5,969	–	–	–
Goodwill	48	47	43	38	42	49	153	173	185	185	252	260	267	303	349	377	326	309	302	320	502	507	530	543	552
Intangible Assets	–	–	–	91	143	133	265	349	381	358	494	464	505	481	700	421	488	450	332	350	365	345	343	326	403
Total Liabilities	2,117	2,119	2,043	1,838	1,823	1,872	2,772	3,295	3,113	3,747	4,178	4,347	4,295	5,347	5,889	5,893	5,784	4,834	5,112	5,576	6,344	6,037	5,590	5,334	6,170
Current Liabilities	939	1,138	1,092	927	897	954	1,538	1,577	1,202	1,466	1,754	1,926	1,960	2,003	2,046	2,023	2,328	1,982	1,761	2,177	2,612	2,606	2,638	2,328	3,131
Short-Term Debt	271	333	559	340	239	267	623	412	104	53	367	604	718	603	673	588	822	610	420	679	577	512	858	384	876
Accounts Payable	177	220	244	267	289	316	428	448	470	521	665	640	669	585	716	644	790	715	712	740	1,064	1,006	912	1,002	1,157
Long-Term Debt	–	–	–	–	–	–	–	–	–	–	–	1,145	1,311	2,304	2,805	2,796	2,388	1,815	2,181	2,093	2,436	2,312	1,625	1,723	1,704
Shareholders' Equity	823	875	948	1,177	1,493	1,734	1,795	2,443	2,774	2,620	3,077	3,375	3,654	2,974	3,028	2,574	2,859	3,781	3,925	3,930	4,527	5,464	5,768	5,724	5,983
Retained Earnings	344	379	419	538	810	810	964	2,074	2,375	2,210	2,699	2,946	3,153	2,692	2,902	2,518	2,691	3,743	3,880	3,752	4,321	5,385	5,583	5,764	5,769
Shares Outstanding	1,200	1,200	1,261	1,239	1,278	1,285	1,286	1,286	1,266	1,272	1,273	1,270	1,270	1,270	1,272	1,274	1,277	1,280	1,282	1,280	1,287	1,290	1,291	1,290	1,291

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings